AzTrials
AzTrials

Fetal DopplerNCT05389553

Fetal Doppler and Uterine Artery Blood Volume Correlation.

An observational study of Fetal Doppler and Uterine Blood Flow, run by University of Campania Luigi Vanvitelli at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

To investigate the relationship between uterine artery blood volume and fetal doppler indices at the delivery. Read more about this study

Who is it for?
Ages 18 to 45 years, women onlyHealthy volunteers can take part
Conditions the study is for
Fetal Doppler, Uterine Blood Flow
What is being tested?
Ultrasound exam
How many people
49 participants
Where
1 siteItaly
Study dates
30 May 2022to 31 Oct 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Study population: Full-term pregnancies (37-42 weeks) comprised all pregnant women who would give birth at our hospital.

Who may be able to join

  • full-term pregnancies (37-42 weeks)

Who cannot join

  • antepartum hemorrhage, fetal growth restriction, stillbirths, multiple gestations, or congenital abnormalities

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • Università degli studi della Campania "Luigi Vanvitelli"- OB & Gyn -

    Naples, Italia, 80138

Other trials in Italy

About this study

Official title: The Association Between Fetal Doppler and Uterine Artery Blood Volume at Term of Pregnancy: A Prospective Observational Study.

To investigate the relationship between uterine artery blood volume and fetal doppler indices at the delivery.

Read the detailed description

Introduction: To investigate the relationship between uterine artery blood volume and fetal doppler indices at the delivery.

Materials and Methods: This was a prospective cohort study of 50 nulliparous women booking antenatal care at the University of Campania "Luigi Vanvitelli" between May 2022 and September 2022. All full-term pregnancies accepted for delivery will include. Pregnant women with antepartum haemorrhage, stillbirths, multiple gestations, or congenital abnormalities were excluded. Women underwent a transabdominal ultrasound examination of uterine arteries for measurement of Uterine artery blood volume. Pregnancy outcomes were recorded, and linear regression was used to study the relationship between uterine artery blood volume and fetal Doppler indices. SPSS version 25 (Chicago, IL, USA) was used to code, tabulate, and analyze the data. Quantitative data were analyzed using the student's t-test. Qualitative data were analyzed using the Mann-Whitney test. A statistically significant difference was defined as a p-value of 0.05.

Being tested
Ultrasound exam
Keywords
Doppler, Pregnancy, ultrasound, uterine blood flow

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ultrasound examOther

    We included all full-term pregnancies accepted for delivery that received an accurate ultrasound scan before the birth

Study groups in NCT05389553
Study groupRoleWhat they receive
Patients at term of pregnancyWe included all full-term pregnancies accepted for delivery that received an accurate ultrasound scan before the birth. Pregnant women with antepartum hemorrhage, fetal growth restriction, stillbirths, multiple gestations, or congenital abnormalities were excluded.
Receives: Other: Ultrasound exam

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. We estimate the uterine volume and its correlation with the fetal doppler indices

    The volume of the uterine arteries will be measured using a doppler ultrasound. We shall also estimate the fetal doppler indices.

    Linear regression will be used to test for a possible relationship between uterus volume blood flow and fetal doppler parameters. Before the delivery, all of these variables will be estimated using an ultrasound exam.

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 May 2022
  2. Study start30 May 2022
  3. Primary completion30 Jun 2022
  4. Study completion31 Oct 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
49 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05389553
Sponsor's protocol ID
0010010/i
Status last verified
Nov 2023
First submitted
20 May 2022
Last updated
27 Nov 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Fetal Doppler and Uterine Blood Flow, run by University of Campania Luigi Vanvitelli at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

We estimate the uterine volume and its correlation with the fetal doppler indices (time frame: 1 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Nov 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in